Your browser doesn't support javascript.
loading
Whole exome sequencing in families with CLL detects a variant in Integrin ß 2 associated with disease susceptibility.
Goldin, Lynn R; McMaster, Mary L; Rotunno, Melissa; Herman, Sarah E M; Jones, Kristine; Zhu, Bin; Boland, Joseph; Burdett, Laurie; Hicks, Belynda; Ravichandran, Sarangan; Luke, Brian T; Yeager, Meredith; Fontaine, Laura; Goldstein, Alisa M; Chanock, Stephen J; Tucker, Margaret A; Wiestner, Adrian; Marti, Gerald; Caporaso, Neil E.
Afiliación
  • Goldin LR; Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
  • McMaster ML; Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
  • Rotunno M; Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD.
  • Herman SE; Hematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD.
  • Jones K; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
  • Zhu B; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
  • Boland J; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
  • Burdett L; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
  • Hicks B; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
  • Ravichandran S; Advanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Luke BT; Advanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Yeager M; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
  • Fontaine L; Westat, Inc, Rockville, MD.
  • Goldstein AM; Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
  • Chanock SJ; Division of Cancer Epidemiology and Genetics, and.
  • Tucker MA; Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and.
  • Wiestner A; Hematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD.
  • Marti G; Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.
  • Caporaso NE; Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
Blood ; 128(18): 2261-2263, 2016 11 03.
Article en En | MEDLINE | ID: mdl-27629550
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antígenos CD18 / Predisposición Genética a la Enfermedad / Mutación Missense Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antígenos CD18 / Predisposición Genética a la Enfermedad / Mutación Missense Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article